Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Sep
26
2023
Updates on China’s Regulation of Food Ingredients and Additives Keller and Heckman LLP
Sep
26
2023
FDA Responds to CFP Recommendations for Food Code Update Keller and Heckman LLP
Sep
26
2023
In Starch Contrast: Australian Patent Office Makes Key Finding on Use of Trade Marks in Patent Specifications K&L Gates
Sep
25
2023
Kraft Recalls “Unpleasant” American Cheese Singles Keller and Heckman LLP
Sep
25
2023
Bonding Requirements Complicate TTB Permit Filing Norris McLaughlin P.A.
Sep
25
2023
Hawaii and California, Seeking to Shed Their Dreary Public Images, Liberalize Psychedelics Bradley Arant Boult Cummings LLP
Sep
22
2023
McDermottPlus Check-Up: September 22, 2023 McDermott Will & Emery
Sep
22
2023
Court Denies Majority of Starbucks “Refresher” Motion to Dismiss Keller and Heckman LLP
Sep
22
2023
Legal Food Talk Episode 22: Supplementing Your Pet’s Lifestyle with Bill Bookout and the National Animal Supplement Council [PODCAST] Greenberg Traurig, LLP
Sep
21
2023
Joint Advisory Warns of Snatch Ransomware Robinson & Cole LLP
Sep
21
2023
Is More Food Safety Regulation Always a Good Thing? Womble Bond Dickinson (US) LLP
Sep
21
2023
Watermelon Sugar: Candy Shape and Color Deemed Functional McDermott Will & Emery
Sep
21
2023
How Alcohol Industry Members Can Prepare for a Government Shutdown McDermott Will & Emery
Sep
20
2023
Ninth Circuit Finds that Costco Is Not Just a Retailer, but Actively Competes with Wholesalers with Respect to Robinson-Patman Price Discrimination Claims K&L Gates
Sep
20
2023
FDA Provides Update on the Cronobacter Prevention Strategy in Powdered Infant Formula Keller and Heckman LLP
Sep
20
2023
Mintz IRA Update — Other Key IRA Programs and Developments: The Medicare Prescription Drug Inflation Rebate Program and Maximum Monthly Cap on Cost-Sharing Payments Program Mintz
Sep
20
2023
Mintz IRA Update — Legal Challenges to the Medicare Drug Price Negotiation Program Mintz
Sep
20
2023
There’s One for You, Nineteen for Me: IRS Issues Guidance on 1900% Pharmaceutical Excise Tax ArentFox Schiff LLP
Sep
20
2023
Mintz IRA Update — A Deeper Dive into Other Controversies of the IRA’s Medicare Drug Price Negotiation Program Mintz
Sep
20
2023
To Reschedule or to Deschedule: That Is the (Marijuana) Question Bradley Arant Boult Cummings LLP
Sep
19
2023
Top Takeaways | Specialty Spotlight: Gastroenterology McDermott Will & Emery
Sep
19
2023
Mississippi Half-Step Uptown Toodeloo: Department of Health Proposes Robust Revisions to Medical Cannabis Regulations Bradley Arant Boult Cummings LLP
Sep
19
2023
Key Takeaways | What the Money Thinks: Investing in Innovative Care Delivery McDermott Will & Emery
Sep
19
2023
FDA: Approval for PTSD MDMA-Assisted Therapy Is One Step Closer Foley & Lardner LLP
Sep
19
2023
Senators Again Urge Enforcement of Dairy Standards of Identity Keller and Heckman LLP
Sep
19
2023
Do Corporate Boards Necessarily Breach Their Fiduciary Duties When They Approve Illegal Conduct? Allen Matkins Leck Gamble Mallory & Natsis LLP
Sep
19
2023
FDA Announces and Seeks Comments on Cosmetics Direct — Portal for Cosmetic Facility Registration and Product Listing ArentFox Schiff LLP
Sep
18
2023
Third Circuit Finds Documentation Issues May Be “Material” under the FCA Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins